Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: Multidetector computed tomography versus magnetic resonance imaging-Reference-Cited by-同舟云学术

Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: Multidetector computed tomography versus magnetic resonance imaging

Published:2014-10 Issue:10 Volume:83 Page:1778-1785
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Zhao Lei,Ma Xiaohai,Feuchtner Gudrun Maria,Zhang Chen,Fan Zhanming

Funder

China National Natural Science Fund Grant

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. Quantitative assessment of left ventricular function with dual source CT in comparison to cardiac magnetic resonance imaging: initial findings;Busch;Eur Radiol,2008

2. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging;Mahnken;J Am Coll Cardiol,2005

3. Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT;Baks;AJR.,2007

4. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction characterization of myocyte death, microvascular obstruction, and chronic scar;Lardo;Circulation,2006

5. Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging;le Polain de Waroux;Eur Heart J,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

2. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06

3. Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024;Arquivos Brasileiros de Cardiologia;2024

4. Feasibility of the Threshold-Based Quantification of Myocardial Fibrosis on Cardiac CT as a Prognostic Marker in Nonischemic Dilated Cardiomyopathy;Korean Journal of Radiology;2024

5. Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024;Arquivos Brasileiros de Cardiologia;2024